View Single Post
Old 09-22-2021, 11:50 PM   #7 (permalink)
Apia resurrected
Senior Member
2022 Marathon Kickstarter Backer2021 Marathon Kickstarter Backer2020 Marathon Kickstarter Backer2019 Marathon Kickstarter Backer24-hour Marathon 2018 Fundraiser Backer24-hour Marathon 2017 Fundraiser Backer47-hour Marathon 2016 Kickstarter Backer57-hour Marathon 2015 Kickstarter Backer38-hour Marathon 2014 Kickstarter Backer54-hour Marathon 2013 Kickstarter Backer
 
Join Date: Mar 2020
Location: Niedernhausen, Germany
Posts: 2,828
Also that some medicine could work less in black people is absolutely racism, the NORMAL
Person in medicine was for a long time a white male. ( no women in studies for different reasons)
The other is money, I explain later more. ( keep them wanting more Apia!)

Ok now.
Basically when you do a clinical study you want to prove significantly. Meaning that the result wasn’t created by chance.
For that you need high numbers of patients.
Because, just imagine if you have a study with only 10 people, the chances that those people are somehow similar for example by having the same blood type is high.
And maybe the drug works especially well or not at all in those similar people.

High numbers of patients should also be reached in all subgroups.
Subgroups could be defined by age, ethnicity, risk, and other objectives.
Many patients in studies= the studies are more expensive = the studies take longer because the recruitment takes longer.
In the past no one cared, clinical trials were way, way smaller.
As far as the drugs showed that they helped the white man, everyone was happy.
This changed with newer drugs.
Studies are done on volunteers who get money for their participation and for taking a drug that isn’t safe yet.
This is a good thing. Other methods would be testing new drugs on prisoners for example and I hope no one really wants it.

Last edited by Apia resurrected; 09-23-2021 at 10:01 AM.
(Offline)   Reply With Quote